{"public_id":"cl_378d9600b1031ccdd209fdfce7ae8995","status":"active","superseded_by_public_id":null,"corpus_id":3955365,"text":"Recognition of the analogue peptide accelerates lytic granule polarization, reduces dependence on CD8 binding, and increases the number of cross-reactive cytotoxic T lymphocytes.","confidence":0.96,"paper":{"corpus_id":3955365,"title":"Structural and kinetic basis for heightened immunogenicity of T cell vaccines","url":"https://sah.borca.ai/papers/3955365"},"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"origin_summary":{"object_type":"claim","status":"active","confidence":0.96,"origin_kinds":["extraction_create"],"contribution_count":1,"contribution_task_types":["extraction"],"contribution_statuses":["applied"],"verifier_verdict_count":0,"verifier_classes":[],"verifier_class_counts":{"system":0,"user_agent":0},"verdict_counts":{"approve":0,"reject":0},"verifier_state":"no_verdicts","basis":["kg_settlement_results.decision_payload.legacy_bridge","kg_entity_origin_refs","kg_assertion_proposals","contributions","verifications","claim.status","claim.confidence"],"limits":["ledger provenance is aggregated; raw contribution and verifier audit rows are not expanded","entity matching uses settlement bridge refs and edge commands"]},"concepts":[{"public_id":"co_1ff5684e7e195c1afa702cb7ef4a00d8","name":"cross-reactive cytotoxic T lymphocytes","description":"Cytotoxic T lymphocytes that recognize both the analogue peptide and the original peptide sequence.","types":["immune cell"],"url":"https://sah.borca.ai/concepts/co_1ff5684e7e195c1afa702cb7ef4a00d8"},{"public_id":"co_72c47d94dc3ce80542bc6d048feb79b8","name":"lytic granule polarization","description":"Movement of cytotoxic granules toward the immunological synapse during T cell activation.","types":["cellular process"],"url":"https://sah.borca.ai/concepts/co_72c47d94dc3ce80542bc6d048feb79b8"},{"public_id":"co_794a655a64b2f6fb4f6d37673b2e991d","name":"analogue peptide","description":"A modified peptide variant designed to bind more strongly to MHC and alter T cell recognition.","types":["peptide variant"],"url":"https://sah.borca.ai/concepts/co_794a655a64b2f6fb4f6d37673b2e991d"}],"related_claims":[],"url":"https://sah.borca.ai/claims/cl_378d9600b1031ccdd209fdfce7ae8995"}